AKT1 and gastric cancer: To further elucidate the causal link between c-Myc and the AKT/mTOR pathway in GC, we transfected c-Myc plasmids into AGS cells and then treated these cells with an AKT inhibitor (MK-2206) or an mTOR inhibitor (rapamycin).